Four institutes coming together as one

TRI accelerates the time between a laboratory discovery and its use in the community. Led by Professor Ian Frazer as Chief Executive Officer and Director of Research, TRI integrates the collective expertise of the University of Queensland Diamantina Institute (UQDI), Queensland University of Technology Institute of Health and Biomedical Innovation (IHBI), Mater Research and the Princess Alexandra Hospital’s Centres for Research.

Collectively our focus is discovering new therapies and vaccines to prevent and treat common and serious illnesses and diseases that affect the community-at-large. These include breast, prostate, blood, head and neck and skin cancers; diabetes and obesity; infectious diseases such as HIV and malaria, and bone and joint diseases such as rheumatoid arthritis.        

TRI also exists as an educational facility in the fields of medicine and science, accommodating University of Queensland’s Faculty of Health Sciences - School of Medicine and School of Nursing and Midwifery, and the flagship school science education program, SPAR Q-ed.